With treatment, the prognosis is excellent, with greater than 97% long-term survival. If untreated,<unk>  progresses to invasive cancer in roughly one-third of cases, usually in the same breast and quadrant as the earlier<unk> . About 2% of women who are diagnosed with this condition and treated died within 10 years. Biomarkers can identify which women who were initially diagnosed with<unk>  are at high or low risk of subsequent invasive cancer.
Ductal carcinoma in situ
Basal cell adenoma
Extramammary Paget's disease
Inverted papilloma
Carcinoma in situ
Lymphomatoid papulosis
Squamous cell papilloma
Lobular carcinoma in situ